These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35426999)

  • 21. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
    Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
    DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression [Retraction].
    Am J Transl Res; 2016; 8(4):1919. PubMed ID: 27186316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma [Retraction].
    Am J Transl Res; 2021; 13(11):13226. PubMed ID: 34956549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retraction: Upregulation of miR-26b alleviates morphine tolerance by inhibiting BDNF
    Fisher L
    RSC Adv; 2021 Jan; 11(7):4231. PubMed ID: 35427020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway [Retraction].
    Am J Transl Res; 2021; 13(12):14240. PubMed ID: 35035772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction].
    Onco Targets Ther; 2020; 13():2525. PubMed ID: 32273722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma [Retraction].
    Am J Cancer Res; 2019; 9(10):2278. PubMed ID: 31720088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma [Retraction].
    Am J Cancer Res; 2020; 10(12):4643. PubMed ID: 33415025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer [Retraction].
    Cancer Manag Res; 2020; 12():11675. PubMed ID: 33235498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p [Retraction].
    Am J Transl Res; 2021; 13(12):14238. PubMed ID: 35035770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of MnSOD and FoxM1 is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells [Retraction].
    Cancer Manag Res; 2022; 14():1473-1474. PubMed ID: 35469135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retraction: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells.
    Fisher L
    RSC Adv; 2021 Jan; 11(9):5265. PubMed ID: 35427004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction].
    Onco Targets Ther; 2021; 14():3597. PubMed ID: 34113125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 [Retraction].
    Onco Targets Ther; 2021; 14():3351. PubMed ID: 34045871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retraction: Synthesis of xanthone derivatives and anti-hepatocellular carcinoma potency evaluation: induced apoptosis.
    Fisher L
    RSC Adv; 2022 Apr; 12(19):11657. PubMed ID: 35503279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00152 Promotes the Growth and Invasion of Oral Squamous Cell Carcinoma by Regulating miR-139-5p [Retraction].
    Onco Targets Ther; 2021; 14():4297. PubMed ID: 34349521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2 [Retraction].
    Cancer Manag Res; 2020; 12():7319. PubMed ID: 32904177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retraction Notice to: Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells.
    Deng T; Zhang H; Yang H; Wang H; Bai M; Sun W; Wang X; Si Y; Ning T; Zhang L; Li H; Ge S; Liu R; Lin D; Li S; Ying G; Ba Y
    Mol Ther Nucleic Acids; 2022 Jun; 28():16. PubMed ID: 35317200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
    Tan A; Li Q; Chen L
    Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Long Noncoding RNA LINC00908 Facilitates Hepatocellular Carcinoma Progression via Interaction with Sox-4 [Retraction].
    Cancer Manag Res; 2022; 14():1443-1444. PubMed ID: 35450394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.